Reproducibility of mRNA-Based Testing of ESR1, PGR, ERBB2, and MKI67 Expression in Invasive Breast Cancer—A Europe-Wide External Quality AssessmentRamona Erber, Fulvia Ferrazzi, Miriam Zentgraf et al.|Cancers|2021Cited by 11
28P Europe-side external quality assessment (EQA) of RNA based testing of ER, PR, HER2 and Ki67 in invasive breast cancerRamona Erber, Fulvia Ferrazzi, Arndt Hartmann et al.|Annals of Oncology|2020Cited by 0
632eP Prevalence of ESR1 mutations in ER+/HER2- advanced breast cancer (aBC) patients treated with everolimus after CDK4/6 inhibitorsFrançois C. Bocquet, Alice Rudolph, M. Campone et al.|Annals of Oncology|2025Cited by 0